Chemcrux Enterprises Limited is an India-based company. The Company is engaged in the business of manufacturing or processing of bulk drug intermediates like para chloro benzoic, ortho benzoic acid, and lasamide, and others. The Company's products include 2-Chloro Benzoic Acid, 3-Chloro Benzoic Acid, 4-Chloro Benzoic Acid, 2,4-Dichloro Benzoic Acid, 4-Chloro 3-Nitro Benzoic Acid; 2-Chloro 5-Nitro Benzoic Acid; Meta Nitro Benzoic Acid; Lasamide, and Meta Chloro Per Benzoic Acid, Para Chloro Benzoyl Chloride, Ortho Chloro Benzoyl Chloride, 2,4-Dichloro Benzoyl Chloride, 2,3-Dichloro Benzoyl Chloride. It is engaged in the development and execution of various processes, such as High-Pressure Oxidation, Nitration, Amidation, BPEA Sulfonamide and Chlorosulfonation. The Company caters to both the domestic and international markets. The Company’s manufacturing facility is located in Bharuch, Gujarat, India.As of 26 May 2026, Chemcrux Enterprises Limited share price is ₹92.25. The stock opened at ₹93.40, compared to its previous close of ₹93.26. During today's trading session, Chemcrux Enterprises Limited share price moved in the range of ₹90.10 to ₹93.40, with an average price of ₹91.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹90.10 and a high of ₹93.40.
The market capitalization of Chemcrux Enterprises Limited is ₹138 Crs, with a P/E ratio of 36.8 and a dividend yield of 1.07%.